Cargando…

Patient, family and productivity costs of end-stage renal disease in the Netherlands; exposing non-healthcare related costs

BACKGROUND: Healthcare costs related to ESRD are well-described, but broader societal costs of ESRD are less known. This study aimed to estimate patient and family costs, including informal care costs and out-of-pocket costs, and costs due to productivity loss related to ESRD, for patients receiving...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries, Eline F., Los, Jeanine, de Wit, G. Ardine, Hakkaart - van Roijen, Leona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520215/ https://www.ncbi.nlm.nih.gov/pubmed/34656083 http://dx.doi.org/10.1186/s12882-021-02548-y

Ejemplares similares

Healthcare costs of patients on different renal replacement modalities – Analysis of Dutch health insurance claims data
por: Mohnen, Sigrid M., et al.
Publicado: (2019)

Association between societal costs and treatment response in children and adolescents with ADHD and their parents. A cross-sectional study in the Netherlands
por: van der Kolk, Annemarie, et al.
Publicado: (2015)

Update of the Dutch manual for costing studies in health care
por: Kanters, Tim A., et al.
Publicado: (2017)

In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era
por: Brouwer, Werner, et al.
Publicado: (2021)

Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands
por: Al, Maiwenn J, et al.
Publicado: (2010)

Age-related difference in health care use and costs of patients with chronic kidney disease and matched controls: analysis of Dutch health care claims data
por: van Oosten, Manon J M, et al.
Publicado: (2019)

The cost-effectiveness of family/family-based therapy for treatment of externalizing disorders, substance use disorders and delinquency: a systematic review
por: Goorden, Maartje, et al.
Publicado: (2016)

Impact of physical activity on healthcare costs: a systematic review
por: Duijvestijn, Marjolein, et al.
Publicado: (2023)

Efficacy and cost-effectiveness of an experimental short-term inpatient Dialectical Behavior Therapy (DBT) program: study protocol for a randomized controlled trial
por: van den Bosch, Louisa M C, et al.
Publicado: (2014)

Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
por: Mangen, Marie-Josée J., et al.
Publicado: (2015)

Orphan drugs expenditure in the Netherlands in the period 2006–2012
por: Kanters, Tim A, et al.
Publicado: (2014)

Cost-effectiveness of blended vs. face-to-face cognitive behavioural therapy for severe anxiety disorders: study protocol of a randomized controlled trial
por: Romijn, Geke, et al.
Publicado: (2015)

Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands
por: van Santen, Daniëla K., et al.
Publicado: (2016)

Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up
por: Romijn, Geke, et al.
Publicado: (2021)

Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?
por: Schawo, Saskia, et al.
Publicado: (2015)

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease
por: Kanters, Tim A., et al.
Publicado: (2017)

Effectiveness and Cost-Effectiveness of eHealth Interventions in Somatic Diseases: A Systematic Review of Systematic Reviews and Meta-Analyses
por: Elbert, Niels J, et al.
Publicado: (2014)

Postponed healthcare in The Netherlands during the COVID-19 pandemic and its impact on self-reported health
por: Visscher, Kirsten, et al.
Publicado: (2023)

Employment and the associated impact on quality of life in people diagnosed with schizophrenia
por: Bouwmans, Clazien, et al.
Publicado: (2015)

Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review
por: van Steenbergen-Weijenburg, Kirsten M, et al.
Publicado: (2010)

Multiplier Effects and Compensation Mechanisms for Inclusion in Health Economic Evaluation: A Systematic Review
por: Krol, Marieke, et al.
Publicado: (2023)

Cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions. A randomized controlled trial in the general hospital setting (CC–DIM)
por: Goorden, Maartje, et al.
Publicado: (2017)

The scope of costs in alcohol studies: Cost-of-illness studies differ from economic evaluations
por: van Gils, Paul F, et al.
Publicado: (2010)

Cost-Effectiveness of Preoperative Screening and Eradication of Staphylococcus aureus Carriage
por: Wassenberg, Marjan W. M., et al.
Publicado: (2011)

Cost of childhood acute otitis media in primary care in the Netherlands: economic analysis alongside a cluster randomised controlled trial
por: van Uum, Rick T., et al.
Publicado: (2021)

Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial
por: Horn, Eva K, et al.
Publicado: (2007)

End-stage renal disease—financial costs and years of life lost in Panama: a cost-analysis study
por: Moreno Velásquez, Ilais, et al.
Publicado: (2019)

In Search for Comparability: The PECUNIA Reference Unit Costs for Health and Social Care Services in Europe
por: Mayer, Susanne, et al.
Publicado: (2022)

Employer-Paid Nonmedical Costs for Patients With Diabetes and End-Stage Renal Disease
por: Kamal-Bahl, Sachin J, et al.
Publicado: (2006)

Feasibility, reliability and validity of a questionnaire on healthcare consumption and productivity loss in patients with a psychiatric disorder (TiC-P)
por: Bouwmans, Clazien, et al.
Publicado: (2013)

Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands
por: Kik, Sandra V, et al.
Publicado: (2009)

Cost-effectiveness of collaborative care including PST and an antidepressant treatment algorithm for the treatment of major depressive disorder in primary care; a randomised clinical trial
por: IJff, Marjoliek A, et al.
Publicado: (2007)

Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D Instruments
por: Łaszewska, Agata, et al.
Publicado: (2022)

Health-care costing in the Netherlands
por: Meijer, R, et al.
Publicado: (2010)

A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs
por: Krol, Marieke, et al.
Publicado: (2015)

Multidisciplinary Collaborative Care for Depressive Disorder in the Occupational Health Setting: design of a randomised controlled trial and cost-effectiveness study
por: Vlasveld, Moniek C, et al.
Publicado: (2008)

Comparison of medical costs generated by IBS patients in primary and secondary care in the Netherlands
por: Flik, Carla E., et al.
Publicado: (2015)

Cost-Effectiveness and Cost-Utility of Internet-Based Computer Tailoring for Smoking Cessation
por: Smit, Eline Suzanne, et al.
Publicado: (2013)

P4 Cost Analysis of Post-COVID-19 Healthcare Consumption in the Netherlands
por: Fens, T, et al.
Publicado: (2022)

Socio-economic determinants of healthcare costs in early life: a register-based study in the Netherlands
por: van der Hulst, Marije, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3k8p66vfoeqj4vf7jhf087fk4a